Therapeutic uses of genome editing with CRISPR/Cas systems
Abstract:
Disclosed herein are methods, compositions, and kits for high efficiency, site-specific genomic editing of cells for treating or preventing genetic blood disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0